Telomeres, the nucleolus and aging

Current Opinion in Cell Biology

Volumn 10, Issue 3, 1998, Pages 332-338

  Johnson, F Brad ^a   Marciniak, Robert A ^a   Guarente, Leonard ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOSOME DNA; TELOMERASE;

ANIMAL CELL; CELL AGING; ENZYME ACTIVATION; GERM CELL; HUMAN; HUMAN CELL; LIFESPAN; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; REVIEW; SENESCENCE; TELOMERE;

ANIMALIA;

EID: 0031805689     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(98)80008-2     Document Type: Article

References (71)

1. Watson JD. Origin of concatemeric T7 DNA. Nature. 239:1972;197-201.
2. Olovnikov A. A theory of marginotomy. J Theor Biol. 41:1973;181-190.
3. Harley C, Futcher A, Greider C. Telomeres shorten during aging of human fibroblasts. Nature. 345:1990;458-460.
4. Lindsey J, McGill N, Lindsey L, Green D, Cooke H. In vivo loss of telomeric repeats with age in humans. Mut Res. 256:1991;45-48.
5. Bodnar A, Ouellette M, Frolkis M, Holt S, Chui C-P, Morin G, Harley C, Shay J, Lichsteiner S, Wright W. Extension of life-span by introduction of telomerase into normal human cells. of outstanding interest Science. 279:1998;349-352 Reconstitution of high levels of telomerase activity in primary human cells lengthened telomeres and extended the replicative life span of cultured cells by at least 20 divisions. Data are presented for two primary human cell types, and unpublished data are mentioned for a third cell type. The cells remained karyotypically normal and lacked at least some of the features of senescent cells. This long awaited experiment provides strong support for a causal role of telomere length in determining the replicative life span of cultured cells.
6. Wright W, Pereira-Smith O, Shay JW. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol. 7:1989;3088-3092.
7. Harley C, Vaziri H, Counter C, Allsopp R. The telomere hypothesis of cellular aging. Exp Gerontol. 27:1992;375-382.
8. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR. Telomerase catalytic subunit homologs from fission yeast and human. of special interest Science. 277:1997;955-959 Genes homologous to those encoding the telomerase catalytic subunits of Euplotes aediculatus and Saccharomyces cerevisiae were cloned from Schizosaccharomyces pombe and humans. All contain sequence homologies to reverse transcriptases, as anticipated for telomerase. The S. pombe gene was shown to be required for maintenance of telomeres, and the expression of the human gene paralleled telomerase activity in cell lines. See also Meyerson 1997 [9] and Kilian 1997 [10].
9. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. of special interest Cell. 90:1997;785-795 Based on sequence similarity at the protein level with telomerase catalytic subunits in lower eukaryotes, a human homologue was cloned. Expression of the mRNA correlates with telomerase activity in normal and cancerous human tissues, as well as during the transition from crisis to immortalization in transformed cultured cells. See also Nakamura 1997 [8] and Kilian 1997 [10].
10. Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR, Jefferson RA. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. of special interest Hum Mol Genet. 6:1997;2011-2019 As in Nakamura [8] and Meyerson [9], the gene for the human telomerase catalytic subunit was cloned based on sequence homology, and expression of the mRNA was found to correlate with telomerase activity in normal and malignant tissues as well as in primary versus immortalized cultured cells. In addition, various tissues and tumors were shown to express different splice forms of the mRNA, raising the possibility that telomerase activity might be regulated by alternative mRNA splicing.
11. Weinrich S, Pruzan R, Libin M, Ouellette M, Tesmer V, Holt S, Bodnar A, Lichtsteiner S, Kim N, Trager J, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic subunit hTRT. of special interest Nat Genet. 17:1997;498-502 Human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTRT) can reconstitute active telomerase enzyme and hTRT is the limiting factor for expression of telomerase activity in fibroblasts. In vitro transcription and translation of hTRT cosynthesized or mixed with the hTR reconstituted telomerase activity. Telomerase activity was reconstituted in normal human fibroblasts by transient transfection of hTRT.
12. Nakayama J-I, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Tahara E, Ide T, Ishikawa F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. of special interest Nat Genet. 18:1998;65-68 Expression of the human telomerase reverse transcriptase (hTRT) is the limiting factor for expression of telomerase activity in fibroblasts. hTRT was transiently transfected into normal human fibroblasts and telomerase activity, which is usually absent in these cells, was restored. Mutant forms of hTRT, altered in domains conserved among reverse transcriptases, did not reconstitute telomerase activity. The expression of hTRT was correlated with telomerase enzymatic activity in multiple samples of human hepatocellular carcinoma.
13. Campisi J, Dimitri G, Hara E. Schneider E, Rowe J. Handbook of the Biology of Aging. 1996;121-149 Academic Press, New York.
14. Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Res. 55:1995;2284-2292.
15. Dimri G, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano E, Linkens M, Rubelj I, Pereira-Smith O, et al. A novel biomarker identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 92:1995;9363-9367.
16. Belair C, Yeager T, Lopez P, Reznikoff C. Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA. 94:1997;13677-13682.
17. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. of outstanding interest Cell. 91:1997;25-34.
18. Martin GM, Sprague CA, Epstein CJ. Replicative life-span of cultivated human cells. Effects of donor's age, tissue, and genotype. Lab Invest. 23:1970;86-92.
19. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissue. Proc Natl Acad Sci USA. 92:1995;11190-11194.
20. Takeda K, Gosiewska A, Peterkofsky B. Similar, but not identical, modulation of extracellular matrix components during in vitro and in vivo aging of human skin fibroblasts. J Cell Phys. 153:1992;450-459.
21. Lansdorp PM, Verwoerd NP, van de Rijke FM, Dragowska V, Little MT, Dirks RW, Raap AK, Tanke HJ. Heterogeneity in telomere length of human chromosomes. of special interest Hum Mol Genet. 5:1996;685-691.
22. Kim N, Piatyszek M, Prowse K, Harley C, West M, Ho P, Coviello G, Wright W, Weinrich S, Shay J. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
23. Broccoli D, Young J, de Lange T. Telomerase activity in normal and malignant hematopoetic cells. Proc Natl Acad Sci USA. 92:1995;9082-9086.
24. Counter C, Gupta J, Harley C, Leber B, Bacchetti S. Telomerase activity in normal lymphocytes and in hematologic malignancies. Blood. 85:1995;2315-2320.
25. Chiu CP, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, Harley CB, Lansdorp PM. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells. 14:1996;239-248.
26. Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H, Ide T, Utakoji T. Telomerase activity in normal human epithelial cells. Oncogene. 13:1996;433-439.
27. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA. 93:1996;6476-6481.
28. Ramirez R, Wright W, Shay J, Taylor R. Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol. 108:1997;113-117.
29. Hiyama E, Hiyama K, Tatsumoto N, Kodama T, Shay J, Yokoyama T. Telomerase activity in human intestine. Int J Oncol. 9:1996;453-458.
30. Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MA. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood. 90:1997;182-193.
31. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek M, Shay J, Ishioka S, Yamakido M. Activation of telomerase in human lymphocytes and hematopoetic progenitor cells. J Immunol. 155:1995;3711-3715.
32. Norrback KF, Dahlenborg K, Carlsson R, Roos G. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood. 88:1996;222-229.
33. Igarashi H, Sakaguchi N. Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem Biophys Res Commun. 219:1996;649-655.
34. Yamada O, Motoji T, Mizoguchi H. Up-regulation of telomerase activity in human lymphocytes. Biochim Biophys Acta. 1314:1996;260-266.
35. Weng NP, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med. 183:1996;2471-2479.
36. Kyo S, Takakura M, Kohama T, Inoue M. Telomerase activity in human endometrium. Cancer Res. 57:1997;610-614.
37. Weng NP, Granger L, Hodes RJ. Telomere lengthening and telomerase activation during human B cell differentiation. of special interest Proc Natl Acad Sci USA. 94:1997;10827-10832.
38. Vaziri H, West MD, Allsopp RC, Davison TS, Wu YS, Arrowsmith CH, Poirier GG, Benchimol S. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. of special interest EMBO J. 16:1997;6018-6033 p53.
39. Marcand S, Gilson E, Shore D. A protein-counting mechanism for telomere length regulation in yeast. of special interest Science. 275:1997;986-990.
40. van Steensel B, de Lange T. Control of telomere length by the human telomeric protein TRF1. of special interest Nature. 385:1997;740-743.
41. Broccoli D, Smogorzewska A, Chong L, de Lange T. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet. 17:1997;231-235.
42. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA. 93:1996;13742-13747.
43. Bond J, Haughton M, Blaydes J, Gire V, Wynford-Thomas D, Wyllie F. Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. Oncogene. 13:1996;2097-2104.
44. Brown JP, Wei W, Sedivy JM. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science. 277:1997;831-834.
45. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602.
46. Xu HJ, Zhou Y, Ji W, Perng GS, Kruzelock R, Kong CT, Bast RC, Mills GB, Li J, Hu SX. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene. 15:1997;2589-2596.
47. Schulz VP, Zakian VA, Ogburn CE, McKay J, Jarzebowicz AA, Edland SD, Martin GM. Accelerated loss of telomeric repeats may not explain accelerated replicative decline of Werner syndrome cells. of special interest Hum Genet. 97:1996;750-754.
48. Kennedy BK, Austriaco NR Jr, Zhang J, Guarente L. Mutation in the silencing gene SIR4 can delay aging in S. cerevisiae. Cell. 80:1995;485-495.
49. Kennedy BK, Gotta M, Sinclair DA, Mills K, McNabb DS, Murthy M, Pak SM, Laroche T, Gasser SM, Guarente L. Redistribution of silencing proteins from telomeres to the nucleolus is associated with extension of life span in S. cerevisiae. of outstanding interest Cell. 89:1997;381-391 The molecular mechanisms of two of the life-extending mutations discovered by an earlier genetic screen, SIR4-42 and UTH4-326, were examined. Using immunofluorescence, SIR4-42 was shown to cause a relocalization of the Sir protein complex from telomeres to the nucleolus, dependent on UTH4 and its homologue YGL023. The same relocalization occurred in old wild-type cells, indicating that the Sir protein complex mitigates an age-related defect in nucleolar function, thereby extending life span.
50. Austriaco NR Jr, Guarente LP. Changes of telomere length cause reciprocal changes in the lifespan of mother cells in Saccharomyces cerevisiae. Proc Natl Acad Sci USA. 94:1997;9768-9772.
51. Smeal T, Claus J, Kennedy B, Cole F, Guarente L. Loss of transcriptional silencing causes sterility in old mother cells of S. cerevisiae. of special interest Cell. 84:1996;633-642 A novel technique was used for efficient purification of old yeast mother cells. Telomeres were shown not to shorten with age, and the age-associated phenotype of sterility was shown to result from loss of silencing by the Sir protein complex at the silent mating type loci.
52. D'Mello NP, Jazwinski SM. Telomere length constancy during aging of Saccharomyces cerevisiae. J Bacteriol. 173:1991;6709-6713.
53. Sinclair DA, Mills K, Guarente L. Accelerated aging and nucleolar fragmentation in yeast sgs1 mutants. of outstanding interest Science. 277:1997;1313-1316 Deletion of SGS1, the yeast homologue of the human Werner syndrome gene, caused premature aging, including early sterility and death. Sgs1p was localized principally to the nucleolus, and old sgs1 cells, as well as old wild-type cells, showed enlargement and fragmentation of the nucleolus. Mutations in SIR3 caused earlier fragmentation, indicating that the Sir protein complex promotes longevity by maintaining nucleolar integrity. This study suggests that an aging mechanism involving changes in nucleolar function may be conserved from yeast to man.
54. Watt PM, Louis EJ, Borts RH, Hickson ID. Sgs1: a eukaryotic homolog of E. coli RecQ that interacts with topoisomerase II in vivo and is required for faithful chromosome segregation. Cell. 81:1995;253-260.
55. Gangloff S, McDonald JP, Bendixen C, Arthur L, Rothstein R. The yeast type I topoisomerase Top3 interacts with Sgs1, a DNA helicase homolog: a potential eukaryotic reverse gyrase. Mol Cell Biol. 14:1994;8391-8398.
56. Lu J, Mullen JR, Brill SJ, Kleff S, Romeo AM, Sternglanz R. Human homologues of yeast helicase [letter]. Nature. 383:1996;678-679.
57. Christman MF, Dietrich FS, Fink GR. Mitotic recombination in the rDNA of S. cerevisiae is suppressed by the combined action of DNA topoisomerases I and II. Cell. 55:1988;413-425.
58. Kim RA, Wang JC. A subthreshold level of DNA topoisomerases leads to the excision of yeast rDNA as extrachromosomal rings. Cell. 57:1989;975-985.
59. Sinclair DA, Guarente L. Extrachromosomal rDNA circles - a cause of aging in yeast. of outstanding interest Cell. 91:1997;1033-1042 The nucleolar fragmentation occurring in old yeast cells (see Sinclair 1997 [53]) was shown to correspond to the accumulation of extrachromosomal ribosomal DNA circles (ERCs). Selective retention of ERCs in yeast mother cells was demonstrated, thereby providing a mechanism for their exponential accumulation in aging cells. Using a Cre-lox-based system to generate ERCs, ERC accumulation was shown to be sufficient to cause premature aging. An allele. of CDC6, which inhibits the replication of episomes, extended life span moderately, suggesting that ERCs are required for yeast aging. Another episome containing an autonomously replicating sequence (ARS) different from the rDNA ARS also caused aging, suggesting that ERCs might inhibit cell replication by sequestering DNA replication factors.
60. Gaubatz JW. Extrachromosomal circular DNAs and genomic sequence plasticity in eukaryotic cells. Mutat Res. 237:1990;271-292.
61. Swisshelm K, Disteche CM, Thorvaldsen J, Nelson A, Salk D. Age-related increase in methylation of ribosomal genes and inactivation of chromosome-specific rRNA gene clusters in mouse. Mutat Res. 237:1990;131-146.
62. Bowman PD, Meek RL, Daniel CW. Decreased synthesis of nucleolar RNA in aging human cells in vitro. Exp Cell Res. 101:1976;434-437.
63. Thomas S, Mukherjee AB. A longitudinal study of human age-related ribosomal RNA gene activity as detected by silver-stained NORs. Mech Ageing Dev. 92:1996;101-109.
64. Lansdorp PM, Dragowska W, Thomas TE, Little MT, Mayani H. Age-related decline in proliferative potential of purified stem cell candidates. Blood Cells. 20:1994;376-381.
65. Michel M, Torok N, Godbout MJ, Lussier M, Gaudreau P, Royal A, Germain L. Keratin 19 as a biochemical marker of skin stem cells in vivo and in vitro: keratin 19 expressing cells are differentially localized in function of anatomic sites, and their number varies with donor age and culture stage. J Cell Sci. 109:1996;1017-1028.
66. Notaro R, Cimmino A, Tabarini D, Rotoli B, Luzzatto L. In vivo telomere dynamics of human hematopoietic stem cells. of special interest Proc Natl Acad Sci USA. 94:1997;13782-13785 Telomeres were found to be shorter in peripheral blood granulocytes of bone marrow transplant recipients after engraftment than in peripheral blood granulocytes of donors. This indicates that hematopoietic stem cells might shorten their telomeres with cell division. It is also conceivable that fewer stem cells are present in the marrow recipients that in the donors, and thus the progeny of those stem cells might divide more times to supply the demand for peripheral blood cells. Thus telomeres would be shorter in the peripheral blood granulocytes because of the additional divisions, rather than because of shortened stem cell telomeres.
67. Strehler BL, Chang M-P, Johnson LK. Loss of hybridizable ribosomal DNA from human post-mitotic tissues during aging: I. Age-dependent loss in human myocardium. Mech Ageing Dev. 11:1979;371-378.
68. Strehler BL, Chang M-P. Loss of hybridizable ribosomal DNA from human post-mitotic tissues during aging: II. Age-dependent loss in human cerebral cortex - hippocampal and somatosensory cortex comparison. Mech Ageing Dev. 11:1979;379-382.
69. Peterson CR, Cryar JR, Gaubatz JW. Constancy of ribosomal RNA genes during aging of mouse heart cells and during serial passage of WI-38 cells. Arch Gerontol Geriatr. 3:1984;115-125.
70. Halle JP, Muller S, Simm A, Adam G. Copy number, epigenetic state and expression of the rRNA genes in young and senescent rat embryo fibroblasts. Eur J Cell Biol. 74:1997;281-288.
71. Autexier C, Greider CW. Telomerase and cancer: revisiting the telomere hypothesis. Trends Biochem Sci. 21:1996;387-391.